Pennant Group, Inc. (PNTG): Capital Expenditures
$12.04M
Year ended 2025-12-31
$18.62M
Trailing 12 months to 2026-06-30
-5.3%
3-year compound annual growth
+10.7%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $12.04M | +33.9% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $8.99M | +10.9% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $8.11M | -42.8% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $14.17M | +124.8% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $6.30M | -13.1% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $7.25M | +8.0% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $6.71M | +86.3% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $3.60M | +15.0% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $3.13M | n/a | 2020-03-04, From 2017-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Pennant Group, Inc. (PNTG) | 2025-12-31 | $12.04M | +33.9% |
| InnovAge Holding Corp. (INNV) | 2026-06-30 | $14.31M | +128.5% |
| U S Physical Therapy Inc (USPH) | 2025-12-31 | $14.07M | +53.2% |
| LifeStance Health Group, Inc. (LFST) | 2025-12-31 | $36.12M | +67.5% |
| P3 Health Partners Inc. (PIII) | 2024-12-31 | $0 | -100.0% |
| GeneDx Holdings Corp. (WGS) | 2025-12-31 | $19.02M | +246.3% |
| DocGo Inc. (DCGO) | 2025-12-31 | $4.54M | +25.8% |
| Omada Health, Inc. (OMDA) | 2025-12-31 | $1.32M | +121.8% |
| Strata Critical Medical, Inc. (SRTA) | 2025-12-31 | $9.60M | -68.9% |
Compare PNTG, INNV, USPH, LFST side by side · Screen every company in Services-Health Services ↗